Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
9(35%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
1
4%
Ph not_applicable
8
31%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution9 total trials
Phase 2Efficacy & side effects
1(11.1%)
N/ANon-phased studies
8(88.9%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

9

trials recruiting

Total Trials

26

all time

Status Distribution
Active(13)
Completed(5)
Other(8)

Detailed Status

Recruiting8
unknown8
Completed5
Not yet recruiting4
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
26
Active
9
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (11.1%)
N/A8 (88.9%)

Trials by Status

active_not_recruiting14%
not_yet_recruiting415%
completed519%
recruiting831%
unknown831%

Recent Activity

Clinical Trials (26)

Showing 20 of 26 trialsScroll for more
NCT03068663Not Applicable

Microbiota and the Lung Cancer

Active Not Recruiting
NCT06047236

Immune Biomarker Study for Salivary Gland Carcinoma

Recruiting
NCT01258036

Mother Daughter Bone Microarchitecture

Completed
NCT07113574Phase 2

Pharmacokinetics of Meropenem and Aztreonam After Intraperitoneal Administration Via Cycler-therapy in APD Patients Without Peritonitis

Completed
NCT05565885

Search for BIO Diagnostic and Prognostic Markers in Adult VAScularitis

Recruiting
NCT05763186Not Applicable

The Right Amount of Purge Useful for Blood Sampling on PiccLine (PiccLine)

Recruiting
NCT06161285

Association of Dysbiosis and Immune Response in Bronchiolitis in Under 12 Months -Old Infants

Recruiting
NCT06608147Not Applicable

MOLyF : Bone Marrow and Follicular Lymphoma

Recruiting
NCT06722131

Biobank of Samples From Patients With Infectious Diseases

Not Yet Recruiting
NCT06599411

Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin Diseases

Not Yet Recruiting
NCT06582654

Normalizing Antibody Detection in First-void Urine

Recruiting
NCT06177353

Study of the Blood and Skin Immunological Profile of Patients With Recessive Dystrophic Epidermolysis Bullosa: in Vivo Analysis and the Impact of Placental Stem Cells in Vitro

Recruiting
NCT06435689

Study and Modulation of Immune Responses in Primary and Metastatic Colon Cancers

Not Yet Recruiting
NCT06244875

Biological Collection of Neurocognitive Disorders

Not Yet Recruiting
NCT05843747Not Applicable

Ex Vivo Transformation of White Adipose Tissue (WAT) Into Brown Adipose Tissue (BAT) in Morbidly Obese Patients Using the Ex Vivo Adipocyte Expansion (ExAdEx) Approach: Proof of Concept. From White to Brown Adipose Tissue

Completed
NCT06142279Not Applicable

Development and Qualification of Methods for Analyzing the Mucosal Immune Response to COVID-19

Unknown
NCT05375266

Immune Biomarker Study for Head and Neck Cancer

Recruiting
NCT03614481

Clinical and Genetic Analyzes of Age-related Macular Degeneration

Unknown
NCT05850039

Study of the Expression of Autophagy Markers in the Myocardium in Patients With Persistent or Permanent Atrial Fibrillation

Unknown
NCT05541835

Hematological Abnormalities in Children

Unknown

Drug Details

Intervention Type
OTHER
Total Trials
26